Aug 24, 2021 / 12:00PM GMT
Operator
Thank you for standing by, and welcome to WuXi Biologics' earnings call. (Operator Instructions) Today's conference call is being recorded. I would now like to turn the call over to your first speaker for today, Ziyi Chen. Please go ahead.
Ziyi Chen - Goldman Sachs Group, Inc., Research Division - Equity Analyst
Thank you. And good evening, good morning to our global investors. Thank you for joining WuXi Biologics First Half 2021 Earnings Call. This is Ziyi Chen, China health care analyst at Goldman Sachs.
Before we kick off the session, I would like to highlight that this call is strictly for clients of Goldman Sachs only, and this conversation is not intended for the media and is off the record, and participants will be removed on the call if they cannot be properly identified. And this call is not for the purpose of sharing or receiving them public or otherwise confidential information.
Today, we are honored to have WuXi Biologics management team on the call to discuss the results and also the recent business updates. Management attending
Half Year 2021 WuXi Biologics (Cayman) Inc Earnings Call Transcript
Feb 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers